Risk of cancer with angiotensin-receptor blockers increases with cumulative exposure: Meta-regression analysis of randomized trials.
4 Mar, 2022 | 08:49h | UTCCommentary: ARBs and Cancer Risk: New Meta-Analysis Raises Questions Again – Medscape (free registration required)